SPOTLIGHT -
Biologic changes in the sleep-wake cycle contribute to inadequate sleep and hypersomnolence in adolescents. Pediatricians should counsel their teenage patients on the these changes.
This is serious: The results of a measles outbreak have harmful outcomes
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, shares her thoughts on the latest issue of Contemporary Pediatrics.
Food Insecurity and the Dangers of Infant Formula Dilution
Pemivibart receives EUA to prevent pre-exposure prophylaxis of COVID in immunocompromised adolescents
The initial dose of pemivibart is 4500 mg, which is administered as a single intravenous infusion. A repeat 4500 mg dose should be administered every 3 months if ongoing protection is needed, stated the FDA.
Demystifying Infant Formula
Influenza, RSV, and COVID-19: Identifying determinants of hospitalization influence
The investigators concluded that age-related risk differences "highlight the necessity for tailored strategies, improving understanding of and treatment development for RVIs."
FDA approves givinostat for Duchenne muscular dystrophy in patients 6 years and up
The decision makes givinostat the first nonsteroidal drug approved to treat patients with all genetic variants of DMD.